Drugs that contain Polidocanol
1. Varithena patents expiration
VARITHENA's oppositions filed in EPO
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| USRE38919 | PROVENSIS | Injectable microfoam containing a sclerosing agent |
Oct, 2014
(9 years ago) | |
| USRE40640 | PROVENSIS | Injectable microfoam containing a sclerosing agent |
Oct, 2016
(7 years ago) | |
| US7604185 | PROVENSIS | Generation of therapeutic microfoam |
May, 2020
(3 years ago) | |
| US8734833 | PROVENSIS | Therapeutic foam |
May, 2020
(3 years ago) | |
| US8323677 | PROVENSIS | Therapeutic foam |
May, 2020
(3 years ago) | |
| US7731986 | PROVENSIS | Therapeutic foam |
Nov, 2024
(6 months from now) | |
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7357336 | PROVENSIS | Generation of therapeutic microfoam |
May, 2020
(3 years ago) | |
| US7025290 | PROVENSIS | Generation of therapeutic microfoam |
May, 2020
(3 years ago) | |
| US6572873 | PROVENSIS | Generation of therapeutic microfoam |
May, 2020
(3 years ago) | |
| US7842282 | PROVENSIS | Generation of therapeutic microfoam |
May, 2020
(3 years ago) | |
| US7842283 | PROVENSIS | Generation of therapeutic microfoam |
May, 2020
(3 years ago) | |
| US6942165 | PROVENSIS | Generation of therapeutic microfoam |
May, 2020
(3 years ago) | |
| US6846412 | PROVENSIS | Combination filter assembly |
Jul, 2022
(1 year, 9 months ago) | |
| US8122917 | PROVENSIS | Apparatus and method for dispensing foam |
Sep, 2024
(4 months from now) | |
| US7814943 | PROVENSIS | Apparatus and method for dispensing foam |
Nov, 2027
(3 years from now) | |
| US9480652 | PROVENSIS | Aerosol valve |
May, 2032
(8 years from now) | |
Market Authorisation Date: 21 December, 2017
Treatment: A method of generating an injectable foam of controlled density and bubble size; A method of using a sclerosing agent for the treatment of incompetent great saphenous veins, accessory saphenous veins ...
Dosage: SOLUTION;INTRAVENOUS
More Information on Dosage
VARITHENA family patents
